Another timely new 🇦🇺study mapping post-RP recurrences (all pre-SRT) on PSMA PET (n=132): bit.ly/39u5FMK. Highlights potential inf undercoverage, importance of posterolat recesses, & possible ant (bladder) overcoverage. Excellent discussion incl caveats. #radonc #pcsm

#radonc #bcsm

Enjoyed this practical overview of radiation myelopathy post spine SBRT from Wee Loon Ong et al. bit.ly/39LnNBV #radonc #pallonc

#radonc LifeOnADT

#radonc #bcsm

A recurring discussion - such is the nature of Twitter (bit.ly/3bpJ2d0). Inevitably #radonc will come across as defensive, so pleasing to see perspective offered by Urologists in this thread Scott Eggener @chrisfilson_uro Brian F. Chapin

Think RT likely to be safe in pts with albinism but will tag others for their thoughts Sushil Catharine West Nadeem Riaz Carmen Bergom MD PhD Henning Willers, MD, FASTRO #radonc

Wonder if #dermtwitter has any thoughts to share on this thread? 👇 Jennifer Choi, MD, FAAD

Respected voices in #skincancer #radonc offering their perspective and urging caution re wide field RT/VMAT for “skin field cancerisation” bit.ly/3YjdyJu

Fantastic overview of recent & historical loc adv #rectalcancer trials & framework for TNT decision-making #radonc #gicsm Tarik Sammour

Would interpret with great caution. Small numbers, retrospective & conflicts with randomised data incl RAPIDO showing equivalent QoL/LARS/late GI tox (bit.ly/3YQMPTS) #radonc #rectalcancer

Full time consultant position available - join our team in Ballarat! 🇦🇺👇 bit.ly/3IMI099

My arguments presented this morning #EAU23 for #radiotherapy + ADT/ARPA in patients with localized high risk PSMA-N1 BRCA mutated #prostatecancer. Major thanks to all who provided input! Two parts: 1. RT/ADT/ARPA is SOC

How will this stack up against the Spratt criteria? 🧐 bit.ly/3JdK60D #radonc #pcsm

New ESTRO ACROP GUIDELINE on Prostate Bed Delineation for Postoperative Radiotherapy in Prostate Cancer! Great work!! ⁦Alan Dal Pra, MD⁩ ⁦Alfonso Gomez-Iturriaga⁩ ⁦Alberto Bossi⁩ sciencedirect.com/science/articl…

🚨🚨🚨 PROSPECT Trial has landed! Congratulations to all investigators, Alliance for Clinical Trials in Oncology, for this important trial! This study is important, will shape, and SHOULD alter practice for OPERATIVELY managed patients with favorable risk LA- rectal cancer. nejm.org/doi/full/10.10…

Let's have a closer look 🧐at the PROSPECT trial after its presentation at #ASCO23 and publication in NEJM bit.ly/43L83oI #radonc #crcsm 1/n

Curious to hear from #radonc re whether they contour & limit lumbosacral plexus when boosting involved pelvic nodes in #prostatecancer? (e.g PEACE V used 65Gy/25# which is 74.75Gy EQD2 for a/b=2) 🤔 Alison Tree 💙 Pierre Blanchard, MD Piet Ost Muhammad Ali Tyler Seibert MD PhD